Turoctocog alfa pegol provides effective management for major and minor surgical procedures in patients across all age groups with severe haemophilia A: Full data set from the pathfinder 3 and 5 phase III trials.
Alberto TosettoAnne NeffSteven R LentzElena SantagostinoLaszlo NemesJameela SatharKarina MeijerPratima ChowdaryChunduo ShenAndrea LandorphKingsley HamptonPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2020)
Turoctocog alfa pegol was effective for perioperative haemostatic management of major and minor surgeries in patients across age groups with severe haemophilia A.